EXE.TO Quote, Financials, Valuation and Earnings

Dentalcorp Holdings Ltd. has a net margin of 5.48% compared to Extendicare, Inc.'s net margin of -1.17%. Extendicare, Inc.'s return on equity of 67.31% beat Dentalcorp Holdings Ltd.'s return on equity of -1.55%.

Extendicare, Inc. has a consensus price target of $23.96, signalling upside risk potential of 7.22%. On the other hand Dentalcorp Holdings Ltd. has an analysts' consensus of $11.44 which suggests that it could grow by 0.55%. Given that Extendicare, Inc. has higher upside potential than Dentalcorp Holdings Ltd., analysts believe Extendicare, Inc. is more attractive than Dentalcorp Holdings Ltd..

Extendicare, Inc. has a beta of 1.133, which suggesting that the stock is 13.26% more volatile than S&P 500. In comparison Dentalcorp Holdings Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Extendicare, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 2.23%. Dentalcorp Holdings Ltd. offers a yield of 0.69% to investors and pays a quarterly dividend of $0.03 per share. Extendicare, Inc. pays 53.75% of its earnings as a dividend. Dentalcorp Holdings Ltd. pays out -- of its earnings as a dividend. Extendicare, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Extendicare, Inc. quarterly revenues are $440.3M, which are larger than Dentalcorp Holdings Ltd. quarterly revenues of $420.1M. Extendicare, Inc.'s net income of $24.1M is higher than Dentalcorp Holdings Ltd.'s net income of -$4.9M. Notably, Extendicare, Inc.'s price-to-earnings ratio is 21.44x while Dentalcorp Holdings Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Extendicare, Inc. is 1.23x versus 1.30x for Dentalcorp Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Medical Facilities Corp. has a net margin of 5.48% compared to Extendicare, Inc.'s net margin of 15.66%. Extendicare, Inc.'s return on equity of 67.31% beat Medical Facilities Corp.'s return on equity of 48.45%.

Extendicare, Inc. has a consensus price target of $23.96, signalling upside risk potential of 7.22%. On the other hand Medical Facilities Corp. has an analysts' consensus of $16.40 which suggests that it could grow by 5.96%. Given that Extendicare, Inc. has higher upside potential than Medical Facilities Corp., analysts believe Extendicare, Inc. is more attractive than Medical Facilities Corp..

Extendicare, Inc. has a beta of 1.133, which suggesting that the stock is 13.26% more volatile than S&P 500. In comparison Medical Facilities Corp. has a beta of 0.241, suggesting its less volatile than the S&P 500 by 75.856%.

Extendicare, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 2.23%. Medical Facilities Corp. offers a yield of 2.35% to investors and pays a quarterly dividend of $0.09 per share. Extendicare, Inc. pays 53.75% of its earnings as a dividend. Medical Facilities Corp. pays out 5.73% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Extendicare, Inc. quarterly revenues are $440.3M, which are larger than Medical Facilities Corp. quarterly revenues of $113.7M. Extendicare, Inc.'s net income of $24.1M is higher than Medical Facilities Corp.'s net income of $17.8M. Notably, Extendicare, Inc.'s price-to-earnings ratio is 21.44x while Medical Facilities Corp.'s PE ratio is 2.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Extendicare, Inc. is 1.23x versus 0.96x for Medical Facilities Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Jack Nathan Medical Corp. has a net margin of 5.48% compared to Extendicare, Inc.'s net margin of -109.67%. Extendicare, Inc.'s return on equity of 67.31% beat Jack Nathan Medical Corp.'s return on equity of --.

Extendicare, Inc. has a consensus price target of $23.96, signalling upside risk potential of 7.22%. On the other hand Jack Nathan Medical Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Extendicare, Inc. has higher upside potential than Jack Nathan Medical Corp., analysts believe Extendicare, Inc. is more attractive than Jack Nathan Medical Corp..

Extendicare, Inc. has a beta of 1.133, which suggesting that the stock is 13.26% more volatile than S&P 500. In comparison Jack Nathan Medical Corp. has a beta of -0.407, suggesting its less volatile than the S&P 500 by 140.741%.

Extendicare, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 2.23%. Jack Nathan Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Extendicare, Inc. pays 53.75% of its earnings as a dividend. Jack Nathan Medical Corp. pays out -- of its earnings as a dividend. Extendicare, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Extendicare, Inc. quarterly revenues are $440.3M, which are larger than Jack Nathan Medical Corp. quarterly revenues of $227.5K. Extendicare, Inc.'s net income of $24.1M is higher than Jack Nathan Medical Corp.'s net income of -$249.5K. Notably, Extendicare, Inc.'s price-to-earnings ratio is 21.44x while Jack Nathan Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Extendicare, Inc. is 1.23x versus 0.11x for Jack Nathan Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Sienna Senior Living, Inc. has a net margin of 5.48% compared to Extendicare, Inc.'s net margin of 4.1%. Extendicare, Inc.'s return on equity of 67.31% beat Sienna Senior Living, Inc.'s return on equity of 6.98%.

Extendicare, Inc. has a consensus price target of $23.96, signalling upside risk potential of 7.22%. On the other hand Sienna Senior Living, Inc. has an analysts' consensus of $22.67 which suggests that it could grow by 7.48%. Given that Sienna Senior Living, Inc. has higher upside potential than Extendicare, Inc., analysts believe Sienna Senior Living, Inc. is more attractive than Extendicare, Inc..

Extendicare, Inc. has a beta of 1.133, which suggesting that the stock is 13.26% more volatile than S&P 500. In comparison Sienna Senior Living, Inc. has a beta of 1.016, suggesting its more volatile than the S&P 500 by 1.621%.

Extendicare, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 2.23%. Sienna Senior Living, Inc. offers a yield of 4.44% to investors and pays a quarterly dividend of $0.08 per share. Extendicare, Inc. pays 53.75% of its earnings as a dividend. Sienna Senior Living, Inc. pays out 185.94% of its earnings as a dividend. Extendicare, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Sienna Senior Living, Inc.'s is not.

Extendicare, Inc. quarterly revenues are $440.3M, which are larger than Sienna Senior Living, Inc. quarterly revenues of $252.7M. Extendicare, Inc.'s net income of $24.1M is higher than Sienna Senior Living, Inc.'s net income of $10.4M. Notably, Extendicare, Inc.'s price-to-earnings ratio is 21.44x while Sienna Senior Living, Inc.'s PE ratio is 47.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Extendicare, Inc. is 1.23x versus 1.93x for Sienna Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.